Institutional investors purchased a net $43.4 thousand shares of PCYC during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 69.02% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
| Mutual fund holders | 34.78% |
| Individual stakeholders | 34.50% |
| Other institutional | 34.24% |